dc.contributor
Institut Català de la Salut
dc.contributor
[Albarrán-Fernández V, Angelats L] Medical Oncology Department, Hospital Clínic, Barcelona, Spain. Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. [Delgado J, Urbano-Ispizua Á] Oncoimmunotherapy Unit, Department of Hematology, Hospital Clínic, Barcelona, Spain. Department of Medicine, University of Barcelona, Barcelona, Spain. [Gros A] Tumor Immunology and Immunotherapy, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Gueda S] Cellular Immunotherapies for Cancer, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain
dc.contributor
Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author
Albarran Fernandez, Victor
dc.contributor.author
Urbano-Ispizua, Alvaro
dc.contributor.author
Guedan Carrio, Sonia
dc.contributor.author
Angelats, Laura
dc.contributor.author
Delgado, Julio
dc.contributor.author
Gros, Alena
dc.date.accessioned
2025-10-25T05:37:26Z
dc.date.available
2025-10-25T05:37:26Z
dc.date.issued
2025-04-01T08:49:51Z
dc.date.issued
2025-04-01T08:49:51Z
dc.date.issued
2025-01-29
dc.identifier
Albarrán-Fernández V, Angelats L, Delgado J, Gros A, Urbano-Ispizua Á, Guedan S, et al. Unlocking the potential of engineered immune cell therapy for solid tumors. Nat Commun. 2025 Jan 29;16:1144.
dc.identifier
http://hdl.handle.net/11351/12860
dc.identifier
10.1038/s41467-025-56527-0
dc.identifier
001410925600007
dc.identifier.uri
http://hdl.handle.net/11351/12860
dc.description.abstract
Immune cell therapy; Solid tumors
dc.description.abstract
Teràpia cel·lular immune, Tumors sòlids
dc.description.abstract
Terapia cel·lular inmune; Tumores sólidos
dc.description.abstract
Adoptive cell therapy has emerged as a promising approach for treating advanced solid malignancies. Genetic engineering techniques represent an exciting area of research for the development of cellular products with enhanced cytotoxicity, phenotype, and metabolism.
dc.format
application/pdf
dc.publisher
Nature Portfolio
dc.relation
Nature Communications;16
dc.relation
https://doi.org/10.1038/s41467-025-56527-0
dc.rights
Attribution-NonCommercial-NoDerivatives 4.0 International
dc.rights
http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.subject
Càncer - Immunoteràpia
dc.subject
Teràpia cel·lular
dc.subject
DISEASES::Neoplasms
dc.subject
Other subheadings::Other subheadings::/therapy
dc.subject
ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Biological Therapy::Immunomodulation::Immunotherapy::Immunization::Immunization, Passive::Adoptive Transfer::Immunotherapy, Adoptive
dc.subject
ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Investigative Techniques::Immunologic Techniques::Immunization::Immunization, Passive::Adoptive Transfer::Immunotherapy, Adoptive
dc.subject
ENFERMEDADES::neoplasias
dc.subject
Otros calificadores::Otros calificadores::/terapia
dc.subject
TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::terapia biológica::inmunomodulación::inmunoterapia::inmunización::inmunización pasiva::transferencia adoptiva::inmunoterapia adoptiva
dc.subject
TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::técnicas de investigación::técnicas inmunológicas::inmunización::inmunización pasiva::transferencia adoptiva::inmunoterapia adoptiva
dc.title
Unlocking the potential of engineered immune cell therapy for solid tumors
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion
